A detailed history of Bbjs Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bbjs Financial Advisors, LLC holds 215 shares of LLY stock, worth $171,069. This represents 0.07% of its overall portfolio holdings.

Number of Shares
215
Previous 215 -0.0%
Holding current value
$171,069
Previous $195 Million 2.15%
% of portfolio
0.07%
Previous 0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $155,847 - $195,443
215 New
215 $195 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bbjs Financial Advisors, LLC Portfolio

Follow Bbjs Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbjs Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbjs Financial Advisors, LLC with notifications on news.